European lung cancer screening: valuable trial evidence for optimal practice implementation-Reference-Cited by-同舟云学术

European lung cancer screening: valuable trial evidence for optimal practice implementation

Published:2022-05-01 Issue:1133 Volume:95 Page:
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Silva Mario¹^ORCID,Milanese Gianluca¹,Ledda Roberta E¹,Nayak Sundeep M²,Pastorino Ugo³,Sverzellati Nicola¹

Affiliation:

1. Scienze Radiologiche, Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy

2. Department of Radiology, Kaiser Permanente Northern California, San Leandro, California, USA

3. Section of Thoracic Surgery, IRCCS Istituto Nazionale Tumori, Milano, Italy

Abstract

Lung cancer screening (LCS) by low-dose computed tomography is a strategy for secondary prevention of lung cancer. In the last two decades, LCS trials showed several options to practice secondary prevention in association with primary prevention, however, the translation from trial to practice is everything but simple. In 2020, the European Society of Radiology and European Respiratory Society published their joint statement paper on LCS. This commentary aims to provide the readership with detailed description about hurdles and potential solutions that could be encountered in the practice of LCS.

Publisher

British Institute of Radiology

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.birpublications.org/doi/pdf/10.1259/bjr.20200260

Reference95 articles.

1. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

2. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials

3. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

4. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen

5. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening